| |
| |
|
| Insider
Information: |
Carter Todd Alfred |
| Relationship: |
Chief Scientific Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
87,627 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$739,572 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
87,627 |
|
|
| Total
Value |
$739,572 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Voyager Therapeutics, Inc. |
VYGR |
Chief Scientific Officer |
2024-02-21 |
87,627 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VYGR |
Voyager Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2024-02-21 |
4 |
S |
$7.47 |
$25,137 |
D/D |
(3,365) |
87,627 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2024-02-20 |
4 |
S |
$7.68 |
$4,623 |
D/D |
(602) |
90,992 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2024-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
38,500 |
91,594 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2024-01-17 |
4 |
S |
$7.18 |
$9,090 |
D/D |
(1,266) |
53,094 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-09-15 |
4 |
AS |
$8.16 |
$85,680 |
D/D |
(10,500) |
54,360 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-09-15 |
4 |
OE |
$2.85 |
$14,250 |
D/D |
5,000 |
64,860 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-07-06 |
4 |
AS |
$10.80 |
$59,400 |
D/D |
(5,500) |
59,860 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-06-30 |
4 |
AS |
$11.41 |
$57,050 |
D/D |
(5,000) |
65,360 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-06-30 |
4 |
OE |
$2.85 |
$14,250 |
D/D |
5,000 |
70,360 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-03-20 |
4 |
AS |
$7.76 |
$17,018 |
D/D |
(2,193) |
65,360 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-02-17 |
4 |
AS |
$7.45 |
$5,498 |
D/D |
(738) |
67,553 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
34,000 |
68,291 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-02-13 |
4 |
AS |
$7.67 |
$6,113 |
D/D |
(797) |
34,291 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-01-17 |
4 |
AS |
$9.57 |
$10,892 |
D/D |
(1,106) |
35,088 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-01-06 |
4 |
S |
$6.41 |
$2,487 |
D/D |
(388) |
36,194 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2022-12-31 |
4 |
A |
$5.17 |
$2,006 |
D/D |
388 |
36,582 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Scientific OfficerOffice |
• – – |
2022-09-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
36,194 |
|
% |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
